Bharat Biotech

Image credit: Twitter/@airnewsalerts - Sakshi Post
Jan 26, 2023
New Delhi: India's first intranasal vaccine against Covid-19 iNCOVACC was launched by Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh in New Delhi on...
 - Sakshi Post
Jan 25, 2023
New Delhi: India’s first intra-nasal Covid-19 vaccine iNCOVACC will be unveiled
Bhaart Biotech's iNCOVACC® nasal vaccine from January 2023 in India  - Sakshi Post
Dec 27, 2022
Hyderabad:Bharat Biotech’s iNCOVACC® is now available on CoWin, priced at Rs 800 for private hospitals and Rs 325 for government hospitals.
 - Sakshi Post
Nov 28, 2022
Hyderabad : Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced that iNCOVACC® (BBV154), has received...
 - Sakshi Post
Nov 17, 2022
We condemn the targeted narrative against COVAXIN put forth by a select few individuals and groups who have no expertise in vaccines or vaccinology.
 - Sakshi Post
Sep 06, 2022
Hyderbad based company Bharat Biotech’s intranasal Covid vaccine has got an official approval from the Drugs Controller General of India (DCGI) for restricted emergency use in those aged above 18...
 - Sakshi Post
Aug 24, 2022
Hyderabad, India, August 24, 2022: Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced its rotavirus...
 - Sakshi Post
Aug 15, 2022
Hyderabad: Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced that BBV154 (intra nasal vaccine) has...
Hyderabad: Bharat Biotech Awaiting Approval For Intranasal COVID-19 Vaccine  - Sakshi Post
Aug 02, 2022
HYDERABAD: Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well,
Persistence Of Immunity And Impact Of 3rd Dose Of Inactivated Covid 19 Vaccine Against Emerging Variants - Sakshi Post
Jul 20, 2022
COVAXIN  demonstrates persistence of immunity and impact of third dose of inactivated  COVID‐19 vaccine against emerging variants.
 - Sakshi Post
May 16, 2022
HYDERABAD: Hyderabad-based Bharat Biotech International Limited on Monday donated Rs 1cr to Bhadrachalam Sri Ramachandra temple. The amount was deposited into the temple's account. 
USFDA Rejects Pediatric Use of India- made Covaxin During Emergency - Sakshi Post
Mar 06, 2022
USFDA Rejects Pediatric Use of India- made Covaxin During Emergency | Ocugen Inc, a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to...
 - Sakshi Post
Jan 29, 2022
The Drugs Controller General of India (DCGI) gave Hyderabad-based vaccine manufacturer Bharat Biotech permission to undertake clinical studies for its intranasal Covid booster dosage in India on...
 - Sakshi Post
Jan 13, 2022
Bharat Biotech on Wednesday said that COVAXIN has a neutralizing effect on the Omicron and Delta variants of COVID-19.
 - Sakshi Post
Jan 05, 2022
The Drugs Controller General of India's (DCGI's) Subject Expert Committee (SEC) has given Bharat Biotech 'in principle' approval to begin a 'Phase III superiority study & Phase III booster dosage...
 - Sakshi Post
Dec 26, 2021
The Drug Controller General of India (DCGI) on Saturday approved Bharat Biotech's COVID-19 vaccine Covaxin for emergency use on children between the ages of 12 and 18. The vaccine is not for children...
Covaxin Gets Shelf Life Extension Of Up To 12 Months - Sakshi Post
Dec 21, 2021
The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's shelf life up to 12 months from the date of manufacture, the vaccine-...
 - Sakshi Post
Oct 27, 2021
The World Health Organization's technical advisory group requested "further clarifications" from Bharat Biotech for its COVID-19 vaccine ‘Covaxin’ on Tuesday in order to complete a final risk-benefit...
Indian Vaccine World Class: Bharat Biotech on UK Travel Curbs - Sakshi Post
Sep 23, 2021
Hyderabad: Suchitra Ella, the Co-founder and Joint Managing Director of Hyderabad-based Bharat Biotech has stated that vaccinations should not be a barrier to entry into any country.
 - Sakshi Post
Aug 31, 2021
Hyderabad-based vaccine maker Bharat Biotech is now working on a partnership with international drugmakers for their vaccine.
Bharat Biotech's Covaxin effective against Delta Plus variant of COVID-19: ICMR study - Sakshi Post
Aug 02, 2021
With Delta Plus variant and Third Wave looming over the country, news is that the Bharat Biotech's COVID-19 vaccine Covaxin is effective against Delta Plus (AY.1) variant of the coronavirus, as...
 - Sakshi Post
Jul 13, 2021
Hyderabad-based Bharat Biotech manufactured vaccine, Covaxin is facing issues with international recognition. Earlier it was reported that Covaxin had not received the approval from World Health...
 - Sakshi Post
Jun 30, 2021
Hyderabad: The city-based Bharat Biotech is now carrying out clinical trials for Covaxin to understand its safety for children.
 - Sakshi Post
Jun 30, 2021
The Bharat Biotech and Indian Council of Medical Research vaccine Covaxin effectively neutralizes the new concerning variants, Alpha and Delta, said the U.S.’ National Institute of Health.
 - Sakshi Post
Jun 25, 2021
The Covaxin Covid-19 vaccine created by Hyderabad-based Bharat Biotech is likely to be administered under emergency authorization and it may soon get full license approval, according to a senior...
 - Sakshi Post
Jun 16, 2021
Bharat Biotech in a reply to the Central Drugs Standard Control Organisation (CDSCO) has said that, "The newborn calf serum is used in the revival process of Vero cells, which is further used for the...
 - Sakshi Post
May 21, 2021
Bharat Biotech announced that it is planning to increase the manufacturing capacity of Covaxin, its Covid-19 vaccine, by an additional 200 million doses per year.
 - Sakshi Post
May 16, 2021
Bharat Biotech on Sunday shared that Covaxin has found to be effective against the coronavirus strains found in India and the UK.
Can Chandrababu Ask His Bharat Biotech Friend to Send Vaccines to AP? - Sakshi Post
May 10, 2021
KAKINADA: Reiterating that the State government is working with an aim to save every single life by fully equipping all the hospitals and Covid Care Centres across the State, Minister for Agriculture...
 - Sakshi Post
Apr 30, 2021
The Telangana government is in talks with Bharat Biotech and Dr Reddy’s Laboratories (DRL) for procuring Covid-19 vaccines in the state to ensure all those above 18 get the jab.
 - Sakshi Post
Apr 28, 2021
Hyderabad-based Bharat Biotech is all ready to increase the production of its indigenously developed Covaxin to 12 million doses a month by July. Currently, the company is producing only 5 million.
Covaxin demonstrates 78 percent efficacy in Phase-3 interim analysis -Bharat Biotech - Sakshi Post
Apr 21, 2021
HYDERABAD: Bharat Biotech-developed Covaxin demonstrated 78 percent efficacy  in treating COVID-19  as per reports released by the company.
 - Sakshi Post
Mar 04, 2021
New Delhi: Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has proved an interim vaccine efficacy of 81 percent in Phase 3 clinical trials.
 - Sakshi Post
Mar 02, 2021
The Indian Pharmaceutical companies became the recent target of cyber security breach and hacking. The hackers or the hacking organizations that are based off in China have been posing a threat to...
 - Sakshi Post
Jan 19, 2021
Bharat Biotech on Monday warned that those who have weaker immunity and people with allergies must not take the Covaxin shot.
 - Sakshi Post
Jan 17, 2021
India has started their COVID-19 vaccination drive and it is said to be one of the world’s largest drives ever. The vaccine will be administered in two separate doses with around 28-days gap in...
 - Sakshi Post
Jan 05, 2021
HYDERABAD: Bharat Biotech has faced a lot of backlash after the recent EUA decision.
 - Sakshi Post
Jan 03, 2021
The Drugs Controller General of India (DCGI) provided Emergency Use Authorization (EUA) to two vaccines in India. The announcement was made earlier today.
 - Sakshi Post
Dec 28, 2020
HYDERABAD: With the spread of coronavirus, every company, manufacturers is trying to develop vaccines as soon as possible. There are as many as five vaccine companies in Hyderabad working on bringing...
 - Sakshi Post
Dec 23, 2020
Bharat Biotech has been conducting research and for the COVID vaccine. For the stage three of COVAXIN trials, around 13,000 volunteers were recruited. The trial will be conducted across multiple...
 - Sakshi Post
Dec 06, 2020
Bharat Biotech has developed Covaxin which is a two-dose vaccine against coronavirus. The Hyderabad based vaccine developer and manufacturer Bharat Biotech has been working on this and have now...
Back to Top